BIOCHEMICAL AND MECHANSIMS OF ACTION OF STUDIES WITH
BIOCHEMICAL AND MECHANSIMS OF ACTION OF STUDIES WITH
批准号:
3609376
负责人:
ROBERT A NEWMAN
金额:
$11.89万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-30 至 1993-09-29
中文摘要
根据本主协议发布的任何主协议订单的目的
协议将确定可能的作用机制,
开发人员感兴趣的潜在抗肿瘤药物
治疗计划(DTP)。 大多数待研究的化合物将
已通过DTP体外人肿瘤细胞系筛选鉴定。
显示特异性差异细胞毒性和/或生长的化合物
将考虑抑制作用以进行进一步评价。 阐发
这种药剂的生化作用机制将被用来帮助
为临床试验的化合物开发设定优先级。 化合物
也可根据其机械性能选择进行机械评价。
抗转移、光敏或放射增敏活性。 因此
所进行的特定生物化学研究可能因化合物而异,
化合物. 将尽可能进行机制评价
使用来自体外筛选的细胞谎言。 研究可以使用
培养的细胞、细胞提取物、纯化的细胞组分,和/或
完整动物和分离组织。 特定的生化效应
评估的可能包括诱导DNA损伤,干扰RNA
处理,核苷酸池大小的变化,DNA结合,
特定的细胞酶(例如,DNA聚合酶、引物酶和甲基化酶;
嘌呤和嘧啶从头合成酶;补救酶;
拓扑异构酶I和II;修复酶),抑制大分子
合成,对微管蛋白和有丝分裂纺锤体的影响,
自由基的形成和与细胞膜成分的相互作用,
蛋白激酶C、G蛋白和其他参与信号传导的受体
转导、生长调节、分化和癌基因表达。
英文摘要
The objective of any Master Agreement Orders issued under this Master
Agreement will be to determine the probable mechanism(s) of action of
potential antitumor agents which are of interest to the Developmental
Therapeutics Program (DTP). The majority of compounds to be studies will
have been identified by the DTP in vitro human tumor cell line screen.
Those compounds demonstrating specific differential cytotoxic and/or growth
inhibitory effects will be considered for further evaluation. Elucidation
of the biochemical mechanism of action of such agents will be used to help
set priorities for development of compounds to clinical trial. Compounds
may also be selected for mechanistic evaluation on the basis of their
antimetastatic, photosensitizing or radiosensitizing activities. Thus, the
specific biochemical studies performed may vary greatly from compound to
compound. Mechanistic evaluations will be conducted wherever possible
using cell lies from the in vitro screen. Studies may be performed with
cultured cells, cellular extracts, purified cellular components, and/or
intact animals and isolated tissues. Specific biochemical effects to be
evaluated may include induction of DNA damage, perturbation of RNA
processing, changes in nucleotide pool sizes, DNA binding, inhibition of
specific cellular enzymes (e.g., DNA polymerases, primases, and methylases;
enzymes of de novo purine and pyrimidine synthesis; salvage enzymes;
topoisomerases I and II; repair enzymes), inhibition of macromolecular
synthesis, effects on tubulin and mitotic spindle, alterations in free
radical formation and interactions with cell membrane components such as
protein kinase C, G proteins and other receptors involved in signal
transduction, growth regulation, differentiation, and oncogene expression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BIOCHEMICAL AND MECHANSIMS OF ACTION OF STUDIES WITH
-
批准号:3609377
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1992
-
负责人:ROBERT A NEWMAN
-
依托单位:
PHARMACOLOGICAL STUDIES OF ANTITUMOR & ANTI-HIV AGENTS
-
批准号:3610242
-
项目类别:
-
资助金额:$0.97万
-
财政年份:1991
-
负责人:ROBERT A NEWMAN
-
依托单位:
PHARMACOLOGICAL STUDIES OF ANTI-TUMOR/HIV AGENTS
-
批准号:3610233
-
项目类别:
-
资助金额:$3.42万
-
财政年份:1991
-
负责人:ROBERT A NEWMAN
-
依托单位:
PHARMACOLOGICAL STUDIES OF ANTI-TUMOR/HIV AGENTS
-
批准号:3610237
-
项目类别:
-
资助金额:$1.73万
-
财政年份:1991
-
负责人:ROBERT A NEWMAN
-
依托单位:
PHARMACOLOGICAL STUDIES OF ANTITUMOR & ANTI-HIV AGENTS
-
批准号:3610243
-
项目类别:
-
资助金额:$1.06万
-
财政年份:1991
-
负责人:ROBERT A NEWMAN
-
依托单位:
PHARMACOLOGICAL STUDIES OF ANTITUMOR & ANTI-HIV AGENTS
-
批准号:3610244
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1991
-
负责人:ROBERT A NEWMAN
-
依托单位:
PHARMACOLOGICAL STUDIES OF ANTI-TUMOR/HIV AGENTS
-
批准号:3610239
-
项目类别:
-
资助金额:$3.44万
-
财政年份:1991
-
负责人:ROBERT A NEWMAN
-
依托单位:
PHARMACOLOGICAL STUDIES OF ANTI-TUMOR/HIV AGENTS
-
批准号:3610236
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1991
-
负责人:ROBERT A NEWMAN
-
依托单位:
BLEOMYCIN MEDIATED PULMONARY TOXICITY
-
批准号:4691055
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROBERT A NEWMAN
-
依托单位:
CORE--BIOCHEMICAL PHARMACOLOGY LABORATORY
-
批准号:4690921
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROBERT A NEWMAN
-
依托单位: